TIF1b is a transcriptional corepressor that recruits repressive chromatin modifiers to target genes. Its biological function and physiological targets in somatic stem cells remain largely unknown. Here, we show that TIF1b is essential for the maintenance of hematopoietic stem cells (HSCs). Deletion of Tif1b in mice induced active cycling and apoptosis of HSCs and promoted egression of HSCs from the bone marrow, leading to rapid depletion of HSCs. Strikingly, Tif1b-deficient HSCs showed a strong trend of ectopic expression of nonhematopoietic genes. Levels of heterochromatin protein 1 (HP1a, b and g) proteins, which form a complex with TIF1b, were significantly reduced in the absence of TIF1b and depletion of HP1 recapitulated a part of the phenotypes of Tif1b-deficient HSCs. These results demonstrate that the TIF1b-HP1 system functions as a critical repressive machinery that targets genes not normally activated in the hematopoietic compartment, thereby maintaining the transcriptional signature specific to HSCs.
INTRODUCTION
During hematopoiesis, hematopoietic stem cells (HSCs) activate specific sets of genes and silence others. Transcription factors fulfill an obvious role in this process. At the same time, chromatin modifiers regulate the accessibility of transcription factors to cis elements by establishing regions of chromatin that are either permissive or repressive to transcription. These epigenetic transcriptional regulations are crucial for the maintenance of multipotency in stem cells (Sauvageau and Sauvageau, 2010; Sashida and Iwama, 2012) . Polycomb group (PcG) proteins, which establish a reversible silencing state through repressive histone modifications, maintain multipotency of HSCs by keeping hematopoietic developmental regulator genes poised for activation via bivalent histone domains (Oguro et al., 2010) . However, the mechanisms by which nonhematopoietic genes, which should never be activated in the hematopoietic cell lineage, are transcriptionally repressed remain to be elucidated.
TIF1b (also called KAP1 or TRIM28) is a transcriptional corepressor that associates with hundreds of Kruppel-associated box domain-zinc finger proteins (KRAB-ZFPs) that bind DNA in a sequence-specific fashion. TIF1b acts as a scaffold for a multimolecular complex that silences transcription through the formation of heterochromatin by recruiting the histone methyltransferase SETDB1, heterochromatin protein 1 (HP1), or the NuRD-histone deacetylase complex (Nielsen et al., 1999; Schultz et al., 2001 Schultz et al., , 2002 . The KRAB/KAP1 system plays a critical role in the control of endogenous retroviruses during development (Rowe et al., 2010 (Rowe et al., , 2013 but also regulates multiple aspects of mammalian physiology. In hematopoiesis, it functions in erythropoiesis and in the prevention of autoinflammatory T cell development (Chikuma et al., 2012; Barde et al., 2013) .
In this study, we demonstrate an essential role for the TIF1b/HP1 system in the maintenance of HSCs and implicate this system in the establishment of transcriptional signature of HSCs by keeping nonhematopoietic genes transcriptionally silent.
RESULTS AND DISCUSSION
Deletion of Tif1b Severely Compromises HSC Function in the Fetal Liver Tif1b-deficient mice show early developmental defects and die by embryonic day 7.5 (E7.5) (Cammas et al., 2000 Figure 1C) . Indeed, Tif1b D/D erythroblasts were mostly proerythroblasts, while the control erythroblasts were at various differentiation stages from proerythroblasts to mature erythroblasts ( Figure 1D ). These data are consistent with the recent reports on the impact of deletion of Tif1b on erythropoiesis (Barde et al., 2013) , suggesting that severe anemia due to impaired erythroid differentiation could account for embryonic lethality of Tie2-Cre;Tif1b fl/fl embryos.
Of note, CD150 + LSK HSCs and LSK HSPCs were also significantly reduced in Tie2-Cre;Tif1b fl/fl fetal livers at E13.5 compared to the controls ( Figures 1E and S1D ). Figure S2E ). We next examined the long-term reconstitution capacity of Tif1b-deficient BM cells. To this end, control and Cre-ERT;Tif1b fl/fl BM cells were transplanted along with the same number of BM competitor cells into lethally irradiated wild-type recipients. Upon deletion of Tif1b at 8 weeks after transplantation, donor cells were rapidly outcompeted by the competitor cells and quickly depleted from both the PB and the BM ( Figure 2H ). In contrast to its role in erythropoiesis (Barde et al., 2013) , the role of TIF1b has never been tested in myeloid cells. We therefore analyzed lysozyme-Cre;Tif1b fl/fl mice, in which Cre is active only in myeloid cells at the maturation stages beyond GMPs. Surprisingly enough, lysozyme-Cre; Tif1b fl/fl mice showed no obvious defects in myeloid differentiation. The hematological data, including the PB cell counts and the lineage composition and the number of BM cells, myeloid progenitor cells and HSCs were almost normal ( Figure S3 ). These findings underline the lineagespecific functions of TIF1b in hematopoiesis.
Loss of HSC Signature in the Absence of TIF1b
To elucidate the changes in gene expression responsible for impaired HSC function in the absence of TIF1b, we performed microarray analysis using LSK cells at 2 weeks postdeletion of Tif1b ( Figure 3A ). The analysis revealed that 541 genes were upregulated more than 2-fold and 486 genes Figure 3B ). This suggests that a loss À LSK cells at 12 weeks after injection of tamoxifen is also shown (right panel). The data are shown as mean ± SEM (n = 6). *p < 0.05; **p < 0.005; ***p < 0.0005.
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Regulation of HSC Signature via TIF1b of ''stemness'' is not responsible for the phenotypes observed in Tif1b-deficient mice.
We next focused on the genes derepressed in the absence of TIF1b. Among genes derepressed, a significant portion of genes became transcriptionally detectable from undetectable levels (''activated'') in Tif1b D/D LSK cells ( Figure 3C ).
We then compared the expression profiles of the ''activated'' genes in Tif1b Figure 3D ). To our surprise, the majority of ''activated'' gene transcripts were not detected in any of these hematopoietic compartments ( Figure 3E ).
These results suggest that TIF1b is required for the gene silencing of nonhematopoietic genes in HSPCs. Among gene sets positively enriched (derepressed) in Tif1b D/D LSK cells, many genes sets were related to signaling pathways mediated by cell surface receptors or adhesion molecules (e.g., integrin signaling pathway, gap junction, and focal adhesion; see Table S1 ) and upregulation of such genes was confirmed by quantitative RT-PCR (Figure S4A) . These results indicate deregulated expression of nonhematopoietic adhesion molecules in Tif1b 
Regulation of HSC Signature via TIF1b Barde et al. (2013) have recently reported that deletion of Tif1b results in compromised erythropoiesis due to failure in the induction of mitophagy-related genes. They found that the TIF1b together with KRAB-ZNF represses the transcription of microRNAs (miRNAs) targeting mitophagy transcripts to induce mitophagy during the terminal differentiation of erythroblasts. Profiling of miRNAs in Tif1b Together, these findings highlight the cell-type-specific as well as differentiation stage-specific functions of TIF1b in hematopoiesis. Nonetheless, it should be noted that some of the upregulated miRNAs potentially target genes downregulated in Tif1b 
Reduction in HP1 Proteins in the Absence of TIF1b
TIF1b physically interacts with all of the HP1 proteins (HP1a, HP1b, and HP1g; Nielsen et al., 1999; Cammas et al., 2002 Cammas et al., , 2007 and recruits them in order to establish deep silencing of their target genes (Nielsen et al., 1999; Schultz et al., 2002 component of heterochromatin where HP1a accumulates, in the absence of TIF1b ( Figure 4B ). These results support the notion that TIF1b functions as a scaffold that stabilizes HP1 proteins. The level of HP1a protein was significantly reduced also in NIH 3T3 cells depleted of TIF1b. However, inhibition of proteasome activity by MG132 in NIH cells failed to stabilize HP1a upon knockdown of Tif1b, leaving the molecular mechanism through which the HP1 proteins are destabilized in the absence of TIF1b still obscure (data not shown). HP1 proteins are recruited to their target loci via physical interaction with TIF1b as well as through direct binding to trimethylated H3K9 to form transcriptionally inactive heterochromatin (Nestorov et al., 2013) . The levels of global histone modifications, including H3K9me1/2/3, did not significantly change in Tif1b D/D Lin À c-KIT + progenitor cells ( Figure S4D ). These findings further suggest that TIF1b regulates HP1 function not only by tethering them to their targets but also by securing their posttranslational stability. In order to test whether the reduction in levels of HP1 proteins is involved in the impaired function of Tif1b D/D HSCs, we knocked down the Hp1 genes in HSCs using small hairpin RNAs (shRNAs) ( Figure S4E ). Growth of HSCs was significantly impaired upon depletion of Hp1a and Hp1g, but not Hp1b ( Figure 4C ). The proportion of LSK HSPCs in GFP + transduced cells was also significantly decreased upon depletion of Hp1a and Hp1g, but not Hp1b, at day 14 of culture ( Figure 4D ). These results suggest that reduced levels of HP1 proteins play a role in determining the phenotypes of Tif1b-deficient HSCs. Together, our findings highlight the TIF1b-HP1 system as critical transcriptional machinery that keeps nonhematopoietic genes repressed in HSCs, thereby maintaining the transcriptional signature specific to HSCs. TIF1b has been reported to repress the expression of endogenous retrotransposons in embryonic stem cells via the histone methyltransferase ESET/SETDB1 and subsequent H3K9 trimethylation (Matsui et al., 2010; Rowe et al., 2010) . However, we did not observe any significant derepression of endogenous retrotransposons in Tif1b MI-2b, a component of the NuRD histone deacetylase complex, which directly interacts with TIF1b (Schultz et al., 2001; Yoshida et al., 2008) . TIF1b may thus collaborate with the NuRD complex, in addition to HP1 proteins, and stabilize these repressor molecules critical for the transcriptional repression of nonhematopoietic genes in HSCs. The epigenetic regulation of transcription is crucial for the maintenance of cell-type-specific signatures (Sashida and Iwama, 2012) . In the point of view of transcriptional regulation, multipotency of stem cells can be defined as an ability of stem cells to express a set of genes required for differentiation and cell-type-specific function upon cell differentiation. The PcG proteins maintain this ''transcriptional competence'' by transiently silencing genes that will be activated during differentiation of stem cells (Sauvageau and Sauvageau, 2010) . In contrast, our findings in this study indicate that the TIF1b-HP1 system, which collaborates with H3K9me3 and DNA methylation (Rowe et al., 2013) , is involved in establishing a more stable silencing state of genes that would never be activated in a given cell lineage. However, the precise mechanisms by which the epigenetic switching between the reversible PcG-mediated system and the TIF1b-HP1 system that we propose here remain to be elucidated. Understanding how these different repressive systems work would prove invaluable to our understanding of the epigenetic regulation of stem cells.
EXPERIMENTAL PROCEDURES
Details regarding experimental procedures are available in Supplemental Experimental Procedures.
